Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Neurofibromin 1 | 14 | 2016 | 190 | 3.160 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 11 | 2024 | 1760 | 2.600 |
Why?
|
ras GTPase-Activating Proteins | 6 | 2023 | 95 | 1.970 |
Why?
|
ras Proteins | 9 | 2024 | 1054 | 1.490 |
Why?
|
Nerve Sheath Neoplasms | 8 | 2016 | 169 | 1.460 |
Why?
|
Genes, Neurofibromatosis 1 | 10 | 2016 | 74 | 1.400 |
Why?
|
Neurofibromatosis 1 | 12 | 2017 | 561 | 1.370 |
Why?
|
Genes, ras | 6 | 2019 | 657 | 1.140 |
Why?
|
MAP Kinase Kinase Kinases | 2 | 2019 | 252 | 1.040 |
Why?
|
Protein Kinase Inhibitors | 9 | 2024 | 5694 | 0.990 |
Why?
|
Genes, Tumor Suppressor | 6 | 2023 | 1059 | 0.820 |
Why?
|
Epigenesis, Genetic | 5 | 2024 | 3834 | 0.820 |
Why?
|
Neoplasms | 17 | 2024 | 22365 | 0.780 |
Why?
|
Mutation | 18 | 2024 | 30211 | 0.760 |
Why?
|
Proto-Oncogene Proteins c-akt | 4 | 2024 | 2456 | 0.680 |
Why?
|
Carrier Proteins | 4 | 2017 | 4937 | 0.670 |
Why?
|
TOR Serine-Threonine Kinases | 6 | 2023 | 2061 | 0.620 |
Why?
|
Cell Line, Tumor | 17 | 2024 | 17128 | 0.600 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 5 | 2023 | 5394 | 0.550 |
Why?
|
Signal Transduction | 18 | 2024 | 23642 | 0.520 |
Why?
|
Antineoplastic Agents | 8 | 2024 | 13658 | 0.490 |
Why?
|
NF-kappa B | 2 | 2016 | 2493 | 0.480 |
Why?
|
Proto-Oncogene Proteins B-raf | 4 | 2019 | 2058 | 0.470 |
Why?
|
Carcinoma, Pancreatic Ductal | 2 | 2023 | 1757 | 0.460 |
Why?
|
Xenograft Model Antitumor Assays | 6 | 2024 | 3609 | 0.450 |
Why?
|
Tumor Suppressor Proteins | 4 | 2014 | 2800 | 0.450 |
Why?
|
Oncogenes | 2 | 2010 | 1232 | 0.420 |
Why?
|
Cafe-au-Lait Spots | 1 | 2012 | 20 | 0.410 |
Why?
|
Histones | 1 | 2023 | 2600 | 0.410 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2017 | 777 | 0.400 |
Why?
|
raf Kinases | 2 | 2010 | 117 | 0.400 |
Why?
|
Ubiquitin-Protein Ligase Complexes | 1 | 2013 | 170 | 0.400 |
Why?
|
Lung Neoplasms | 5 | 2023 | 13499 | 0.400 |
Why?
|
Animals | 42 | 2024 | 169222 | 0.390 |
Why?
|
Mice | 29 | 2024 | 82024 | 0.380 |
Why?
|
Melanoma | 5 | 2019 | 5706 | 0.380 |
Why?
|
Molecular Targeted Therapy | 6 | 2024 | 2824 | 0.380 |
Why?
|
Colonic Neoplasms | 1 | 2023 | 2540 | 0.370 |
Why?
|
Benzoquinones | 1 | 2011 | 198 | 0.360 |
Why?
|
Homeodomain Proteins | 1 | 2020 | 2429 | 0.350 |
Why?
|
Cell Differentiation | 2 | 2024 | 11665 | 0.350 |
Why?
|
Disease Models, Animal | 12 | 2020 | 18344 | 0.340 |
Why?
|
GTPase-Activating Proteins | 5 | 2016 | 468 | 0.340 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 3 | 2023 | 635 | 0.340 |
Why?
|
Lactams, Macrocyclic | 1 | 2011 | 319 | 0.330 |
Why?
|
Drug Discovery | 1 | 2017 | 1068 | 0.330 |
Why?
|
DNA Repair | 1 | 2019 | 2050 | 0.330 |
Why?
|
Drug Resistance, Neoplasm | 5 | 2024 | 5335 | 0.330 |
Why?
|
Cell Death | 3 | 2024 | 1679 | 0.320 |
Why?
|
Neurofibromatosis 2 | 4 | 2014 | 387 | 0.310 |
Why?
|
Nerve Tissue Proteins | 4 | 2015 | 4414 | 0.310 |
Why?
|
Proteasome Endopeptidase Complex | 3 | 2013 | 1319 | 0.310 |
Why?
|
Repressor Proteins | 2 | 2012 | 2982 | 0.300 |
Why?
|
Receptors, Thrombin | 4 | 1999 | 130 | 0.300 |
Why?
|
Pancreatic Neoplasms | 2 | 2023 | 5446 | 0.290 |
Why?
|
Sirolimus | 2 | 2011 | 1538 | 0.270 |
Why?
|
Cell Transformation, Neoplastic | 4 | 2016 | 2846 | 0.270 |
Why?
|
MAP Kinase Signaling System | 2 | 2013 | 1492 | 0.270 |
Why?
|
Glioblastoma | 2 | 2013 | 3463 | 0.260 |
Why?
|
Genes, p53 | 4 | 2013 | 711 | 0.250 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2013 | 2889 | 0.250 |
Why?
|
Gene Expression Regulation, Neoplastic | 6 | 2023 | 8637 | 0.240 |
Why?
|
Colorectal Neoplasms | 1 | 2024 | 6973 | 0.240 |
Why?
|
Azepines | 2 | 2018 | 329 | 0.230 |
Why?
|
Transcription Factors | 4 | 2018 | 12165 | 0.220 |
Why?
|
Drug Synergism | 2 | 2024 | 1760 | 0.220 |
Why?
|
Eukaryotic Initiation Factor-4F | 1 | 2023 | 41 | 0.210 |
Why?
|
Humans | 53 | 2024 | 767991 | 0.210 |
Why?
|
Platelet Activation | 4 | 1997 | 644 | 0.210 |
Why?
|
Cell Cycle Proteins | 4 | 2018 | 3443 | 0.200 |
Why?
|
Mice, Nude | 3 | 2020 | 3620 | 0.200 |
Why?
|
Organ Specificity | 2 | 2024 | 1968 | 0.190 |
Why?
|
Protein Kinases | 2 | 2007 | 1610 | 0.190 |
Why?
|
Quinolines | 2 | 2024 | 770 | 0.180 |
Why?
|
Thrombin | 5 | 1999 | 600 | 0.180 |
Why?
|
Triazoles | 2 | 2018 | 904 | 0.180 |
Why?
|
Nuclear Proteins | 2 | 2018 | 5799 | 0.180 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 3 | 2024 | 11873 | 0.180 |
Why?
|
Acrylonitrile | 1 | 2020 | 19 | 0.180 |
Why?
|
Transcription, Genetic | 1 | 2014 | 7612 | 0.180 |
Why?
|
Tumor Cells, Cultured | 3 | 2020 | 6119 | 0.170 |
Why?
|
Neoplasm Transplantation | 2 | 2016 | 2014 | 0.170 |
Why?
|
Peripheral Nervous System Neoplasms | 1 | 2001 | 133 | 0.170 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2023 | 456 | 0.170 |
Why?
|
Interleukin-1alpha | 1 | 2020 | 88 | 0.170 |
Why?
|
Prenylation | 1 | 2019 | 37 | 0.170 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2015 | 3626 | 0.160 |
Why?
|
Multiprotein Complexes | 2 | 2016 | 1110 | 0.160 |
Why?
|
Neoplasm Metastasis | 3 | 2016 | 4904 | 0.160 |
Why?
|
Glioma | 2 | 2014 | 3503 | 0.150 |
Why?
|
Histone Deacetylases | 1 | 2023 | 717 | 0.150 |
Why?
|
Neurofibromatoses | 2 | 2014 | 303 | 0.150 |
Why?
|
MAP Kinase Kinase 1 | 1 | 2020 | 330 | 0.150 |
Why?
|
Blood Platelets | 5 | 1999 | 2479 | 0.150 |
Why?
|
NIH 3T3 Cells | 2 | 2013 | 668 | 0.150 |
Why?
|
rab GTP-Binding Proteins | 1 | 2019 | 247 | 0.150 |
Why?
|
Genes, Neoplasm | 1 | 2019 | 369 | 0.140 |
Why?
|
Neurofibroma | 2 | 2011 | 95 | 0.140 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2023 | 1405 | 0.140 |
Why?
|
Membrane Proteins | 2 | 2018 | 7876 | 0.130 |
Why?
|
Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 1999 | 577 | 0.130 |
Why?
|
Nucleocytoplasmic Transport Proteins | 1 | 2016 | 73 | 0.130 |
Why?
|
Oxidative Stress | 3 | 2018 | 3140 | 0.130 |
Why?
|
Proto-Oncogene Proteins c-myc | 2 | 2018 | 998 | 0.120 |
Why?
|
Cyclin-Dependent Kinase 6 | 1 | 2018 | 353 | 0.120 |
Why?
|
Cholesterol | 1 | 2024 | 2914 | 0.120 |
Why?
|
NF-E2-Related Factor 2 | 1 | 2018 | 381 | 0.120 |
Why?
|
Integrins | 2 | 1997 | 842 | 0.120 |
Why?
|
Adaptive Immunity | 1 | 2020 | 733 | 0.120 |
Why?
|
Proto-Oncogene Proteins | 4 | 2005 | 4525 | 0.120 |
Why?
|
3T3 Cells | 2 | 2009 | 1084 | 0.120 |
Why?
|
Phosphatidylinositol 3-Kinases | 4 | 2006 | 2884 | 0.120 |
Why?
|
Neoplasms, Nerve Tissue | 1 | 2014 | 20 | 0.120 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2018 | 564 | 0.120 |
Why?
|
Drug Therapy, Combination | 1 | 2024 | 6314 | 0.120 |
Why?
|
Aniline Compounds | 1 | 2020 | 1094 | 0.120 |
Why?
|
Germ-Line Mutation | 2 | 2019 | 1883 | 0.110 |
Why?
|
Interleukin-1beta | 1 | 2020 | 1027 | 0.110 |
Why?
|
Class Ia Phosphatidylinositol 3-Kinase | 1 | 2014 | 77 | 0.110 |
Why?
|
Glucose Transporter Type 1 | 1 | 2014 | 186 | 0.110 |
Why?
|
Proteins | 3 | 2020 | 6009 | 0.110 |
Why?
|
Neoplasm Invasiveness | 2 | 2013 | 3618 | 0.110 |
Why?
|
Anilides | 1 | 2016 | 413 | 0.110 |
Why?
|
Phosphorylation | 4 | 2016 | 8314 | 0.110 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 2 | 2018 | 615 | 0.100 |
Why?
|
Indoles | 3 | 2017 | 1835 | 0.100 |
Why?
|
Cullin Proteins | 1 | 2013 | 180 | 0.100 |
Why?
|
Cell Growth Processes | 1 | 2012 | 381 | 0.100 |
Why?
|
Mice, Inbred BALB C | 3 | 2020 | 6231 | 0.100 |
Why?
|
Breast Neoplasms | 2 | 2016 | 21206 | 0.100 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2016 | 756 | 0.100 |
Why?
|
Cyclins | 2 | 2018 | 605 | 0.090 |
Why?
|
Neurilemmoma | 2 | 2014 | 522 | 0.090 |
Why?
|
Adaptation, Physiological | 1 | 2018 | 1311 | 0.090 |
Why?
|
Protein Stability | 1 | 2013 | 579 | 0.090 |
Why?
|
eIF-2 Kinase | 1 | 2011 | 147 | 0.090 |
Why?
|
Cell Proliferation | 3 | 2024 | 10470 | 0.090 |
Why?
|
In Situ Nick-End Labeling | 1 | 2011 | 610 | 0.090 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2014 | 572 | 0.090 |
Why?
|
Cell Line | 6 | 2018 | 15597 | 0.090 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2024 | 3251 | 0.080 |
Why?
|
Schwann Cells | 2 | 2001 | 196 | 0.080 |
Why?
|
src-Family Kinases | 1 | 1992 | 539 | 0.080 |
Why?
|
Melanocytes | 1 | 2012 | 509 | 0.080 |
Why?
|
Glutathione | 1 | 2011 | 589 | 0.080 |
Why?
|
HSP90 Heat-Shock Proteins | 1 | 2011 | 422 | 0.080 |
Why?
|
Ubiquitination | 1 | 2013 | 1008 | 0.080 |
Why?
|
Receptors, Interleukin-8B | 1 | 2008 | 58 | 0.080 |
Why?
|
Cyclin D | 1 | 2007 | 71 | 0.070 |
Why?
|
Disease Progression | 2 | 2016 | 13665 | 0.070 |
Why?
|
Carcinoma | 1 | 2019 | 2330 | 0.070 |
Why?
|
Pyridines | 2 | 2018 | 2893 | 0.070 |
Why?
|
Fluorescent Antibody Technique | 2 | 2011 | 2473 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-vav | 2 | 1999 | 91 | 0.070 |
Why?
|
RNA Interference | 2 | 2018 | 2830 | 0.070 |
Why?
|
Insulin-Like Growth Factor Binding Proteins | 1 | 2008 | 208 | 0.070 |
Why?
|
Sulfonamides | 2 | 2017 | 1982 | 0.070 |
Why?
|
Prostatic Neoplasms | 1 | 2010 | 11101 | 0.070 |
Why?
|
Genes, Neurofibromatosis 2 | 2 | 2011 | 122 | 0.070 |
Why?
|
GTP-Binding Proteins | 3 | 1997 | 948 | 0.070 |
Why?
|
Genes, Retinoblastoma | 1 | 2006 | 125 | 0.070 |
Why?
|
Mice, Knockout | 4 | 2020 | 14486 | 0.070 |
Why?
|
Neoplasm Proteins | 2 | 2018 | 3601 | 0.070 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2020 | 4648 | 0.070 |
Why?
|
Chromatin | 2 | 2016 | 2981 | 0.060 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2013 | 1656 | 0.060 |
Why?
|
Cells, Cultured | 4 | 2013 | 19017 | 0.060 |
Why?
|
Endoplasmic Reticulum | 1 | 2011 | 1133 | 0.060 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2014 | 2054 | 0.060 |
Why?
|
Female | 14 | 2024 | 397113 | 0.060 |
Why?
|
Transplantation, Heterologous | 1 | 2013 | 2392 | 0.060 |
Why?
|
Protein Kinase C | 1 | 2009 | 1207 | 0.060 |
Why?
|
Precancerous Conditions | 1 | 2011 | 984 | 0.060 |
Why?
|
Sterol Regulatory Element Binding Protein 2 | 1 | 2024 | 58 | 0.060 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2011 | 2953 | 0.060 |
Why?
|
Enzyme Activation | 1 | 2010 | 3587 | 0.060 |
Why?
|
Receptor, erbB-3 | 1 | 2005 | 142 | 0.060 |
Why?
|
Apoptosis | 1 | 2020 | 9521 | 0.060 |
Why?
|
Mice, SCID | 2 | 2020 | 2627 | 0.060 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2007 | 627 | 0.060 |
Why?
|
Transcriptional Activation | 1 | 2010 | 1752 | 0.060 |
Why?
|
Adenosine Triphosphate | 1 | 2010 | 2004 | 0.050 |
Why?
|
Trans-Activators | 1 | 2013 | 2857 | 0.050 |
Why?
|
Antibodies, Monoclonal | 2 | 2020 | 9252 | 0.050 |
Why?
|
Reactive Oxygen Species | 1 | 2011 | 2149 | 0.050 |
Why?
|
Interleukins | 1 | 2008 | 796 | 0.050 |
Why?
|
p120 GTPase Activating Protein | 1 | 2003 | 35 | 0.050 |
Why?
|
Mitogen-Activated Protein Kinases | 2 | 2010 | 1244 | 0.050 |
Why?
|
Feedback | 1 | 2006 | 798 | 0.050 |
Why?
|
Immunoprecipitation | 1 | 2005 | 874 | 0.050 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2018 | 4050 | 0.050 |
Why?
|
Protein-Tyrosine Kinases | 1 | 1992 | 2428 | 0.050 |
Why?
|
Neurons | 2 | 2018 | 9518 | 0.050 |
Why?
|
RNA, Small Interfering | 1 | 2011 | 3428 | 0.050 |
Why?
|
Polymerase Chain Reaction | 1 | 2011 | 6071 | 0.050 |
Why?
|
Mitochondria | 2 | 2015 | 3681 | 0.050 |
Why?
|
Down-Regulation | 1 | 2009 | 2936 | 0.050 |
Why?
|
Stem Cells | 3 | 2006 | 3537 | 0.050 |
Why?
|
Mice, Transgenic | 2 | 2007 | 9556 | 0.050 |
Why?
|
Cell Movement | 1 | 2013 | 5209 | 0.050 |
Why?
|
Chimera | 2 | 1999 | 454 | 0.050 |
Why?
|
Mice, Inbred C57BL | 4 | 2020 | 22381 | 0.050 |
Why?
|
Genetic Predisposition to Disease | 2 | 2019 | 18062 | 0.050 |
Why?
|
Immunoblotting | 2 | 1996 | 1647 | 0.050 |
Why?
|
Male | 10 | 2023 | 364641 | 0.040 |
Why?
|
Lysophospholipids | 1 | 2003 | 338 | 0.040 |
Why?
|
Platelet-Derived Growth Factor | 1 | 2003 | 617 | 0.040 |
Why?
|
Cysteine Endopeptidases | 1 | 2003 | 542 | 0.040 |
Why?
|
Epidermal Growth Factor | 1 | 2003 | 697 | 0.040 |
Why?
|
Peripheral Nervous System | 1 | 2001 | 151 | 0.040 |
Why?
|
Models, Biological | 2 | 2010 | 9493 | 0.040 |
Why?
|
Multienzyme Complexes | 1 | 2003 | 664 | 0.040 |
Why?
|
Communication Disorders | 1 | 1999 | 50 | 0.040 |
Why?
|
Sequence Homology | 1 | 2019 | 197 | 0.040 |
Why?
|
S100 Proteins | 1 | 1999 | 216 | 0.040 |
Why?
|
Maleimides | 1 | 1999 | 112 | 0.040 |
Why?
|
Receptor, PAR-1 | 1 | 1999 | 109 | 0.040 |
Why?
|
Quinazolines | 1 | 2005 | 1369 | 0.040 |
Why?
|
Amino Acid Sequence | 4 | 2019 | 13420 | 0.040 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 1999 | 826 | 0.040 |
Why?
|
Genotype | 1 | 2012 | 13042 | 0.040 |
Why?
|
E2F Transcription Factors | 1 | 2018 | 270 | 0.040 |
Why?
|
Ubiquitin | 1 | 2003 | 843 | 0.040 |
Why?
|
Positron-Emission Tomography | 1 | 2014 | 6668 | 0.040 |
Why?
|
Gene Expression Regulation | 2 | 2007 | 11930 | 0.040 |
Why?
|
Loss of Heterozygosity | 1 | 1999 | 663 | 0.040 |
Why?
|
Transfection | 1 | 2005 | 5757 | 0.040 |
Why?
|
Monomeric GTP-Binding Proteins | 1 | 2018 | 199 | 0.030 |
Why?
|
Embryonic and Fetal Development | 1 | 1997 | 420 | 0.030 |
Why?
|
Oximes | 1 | 2017 | 303 | 0.030 |
Why?
|
Platelet Adhesiveness | 1 | 1996 | 154 | 0.030 |
Why?
|
Fibrinogen | 1 | 1999 | 891 | 0.030 |
Why?
|
Genetic Vectors | 1 | 2005 | 3402 | 0.030 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2018 | 507 | 0.030 |
Why?
|
Phosphotyrosine | 1 | 1996 | 458 | 0.030 |
Why?
|
src Homology Domains | 1 | 1996 | 361 | 0.030 |
Why?
|
Pyrimidinones | 1 | 2017 | 386 | 0.030 |
Why?
|
Peptide Fragments | 2 | 1999 | 5151 | 0.030 |
Why?
|
Molecular Conformation | 1 | 2016 | 540 | 0.030 |
Why?
|
Craniocerebral Trauma | 1 | 1999 | 493 | 0.030 |
Why?
|
Gene Expression | 2 | 2018 | 7597 | 0.030 |
Why?
|
Oncogene Proteins | 1 | 2018 | 717 | 0.030 |
Why?
|
Recombinant Fusion Proteins | 1 | 2003 | 3740 | 0.030 |
Why?
|
Skin Neoplasms | 1 | 2014 | 5861 | 0.030 |
Why?
|
Heterozygote | 1 | 2001 | 2798 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2018 | 1837 | 0.030 |
Why?
|
Central Nervous System | 1 | 2001 | 1346 | 0.030 |
Why?
|
Deglutition Disorders | 1 | 1999 | 640 | 0.030 |
Why?
|
Structure-Activity Relationship | 2 | 2016 | 3055 | 0.030 |
Why?
|
Receptors, Cell Surface | 2 | 1992 | 2819 | 0.030 |
Why?
|
Cell Adhesion | 1 | 1999 | 3096 | 0.030 |
Why?
|
Kinetics | 3 | 1996 | 6328 | 0.030 |
Why?
|
DNA-Binding Proteins | 1 | 2010 | 9614 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-yes | 1 | 1992 | 17 | 0.030 |
Why?
|
Benzimidazoles | 1 | 2017 | 863 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-fyn | 1 | 1992 | 114 | 0.020 |
Why?
|
Enzyme Inhibitors | 1 | 2003 | 3726 | 0.020 |
Why?
|
Pyridones | 1 | 2017 | 819 | 0.020 |
Why?
|
Oxidation-Reduction | 1 | 2018 | 2227 | 0.020 |
Why?
|
Extracellular Matrix Proteins | 1 | 1996 | 832 | 0.020 |
Why?
|
Activities of Daily Living | 2 | 1999 | 2429 | 0.020 |
Why?
|
Imidazoles | 1 | 2017 | 1168 | 0.020 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p15 | 1 | 2011 | 76 | 0.020 |
Why?
|
Pedigree | 1 | 2019 | 4539 | 0.020 |
Why?
|
Drug Design | 1 | 2016 | 1045 | 0.020 |
Why?
|
Estradiol | 1 | 2017 | 1951 | 0.020 |
Why?
|
Comparative Genomic Hybridization | 1 | 2011 | 474 | 0.020 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2015 | 686 | 0.020 |
Why?
|
Alleles | 1 | 2001 | 6894 | 0.020 |
Why?
|
Karyotyping | 1 | 2011 | 1176 | 0.020 |
Why?
|
Enhancer Elements, Genetic | 1 | 2016 | 1367 | 0.020 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2017 | 1536 | 0.020 |
Why?
|
Evolution, Molecular | 1 | 2017 | 1896 | 0.020 |
Why?
|
Platelet Aggregation | 1 | 1992 | 769 | 0.020 |
Why?
|
Phosphoproteins | 1 | 1997 | 2450 | 0.020 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2011 | 706 | 0.020 |
Why?
|
Hematopoiesis | 1 | 1997 | 2059 | 0.020 |
Why?
|
Clathrin | 1 | 1989 | 258 | 0.020 |
Why?
|
Molecular Sequence Data | 3 | 1996 | 17617 | 0.020 |
Why?
|
Cyclic AMP | 1 | 1992 | 1471 | 0.020 |
Why?
|
Antibodies | 1 | 1996 | 2421 | 0.020 |
Why?
|
Zebrafish | 1 | 2019 | 3036 | 0.020 |
Why?
|
Piperazines | 1 | 2018 | 2552 | 0.020 |
Why?
|
Collagen | 1 | 1996 | 2641 | 0.020 |
Why?
|
Protein Binding | 1 | 1999 | 9343 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2020 | 3948 | 0.020 |
Why?
|
Models, Molecular | 1 | 2016 | 5402 | 0.020 |
Why?
|
Calcium | 1 | 1999 | 5794 | 0.020 |
Why?
|
Cognition Disorders | 1 | 1999 | 3977 | 0.020 |
Why?
|
Chromosome Aberrations | 1 | 2011 | 1777 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2016 | 5798 | 0.010 |
Why?
|
Aspirin | 1 | 1996 | 3135 | 0.010 |
Why?
|
Prevalence | 1 | 2001 | 15867 | 0.010 |
Why?
|
Peptides | 2 | 1992 | 4354 | 0.010 |
Why?
|
Meningioma | 1 | 2011 | 1220 | 0.010 |
Why?
|
DNA Copy Number Variations | 1 | 2011 | 2048 | 0.010 |
Why?
|
CHO Cells | 1 | 2005 | 1379 | 0.010 |
Why?
|
Epinephrine | 2 | 1997 | 793 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 1999 | 15944 | 0.010 |
Why?
|
Lymphocytes | 1 | 1989 | 2614 | 0.010 |
Why?
|
Cricetinae | 1 | 2005 | 2423 | 0.010 |
Why?
|
Cerebrovascular Disorders | 1 | 1987 | 1484 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2016 | 9536 | 0.010 |
Why?
|
Brain Neoplasms | 1 | 2001 | 9116 | 0.010 |
Why?
|
Lymphocyte Activation | 1 | 1989 | 5505 | 0.010 |
Why?
|
Ovarian Neoplasms | 1 | 2015 | 4915 | 0.010 |
Why?
|
Rehabilitation Centers | 1 | 1999 | 249 | 0.010 |
Why?
|
Thromboxane A2 | 1 | 1997 | 87 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2019 | 59598 | 0.010 |
Why?
|
Aged | 4 | 2019 | 171446 | 0.010 |
Why?
|
Molecular Weight | 1 | 1997 | 2173 | 0.010 |
Why?
|
Middle Aged | 4 | 2019 | 223422 | 0.010 |
Why?
|
Gene Targeting | 1 | 1997 | 841 | 0.010 |
Why?
|
Adult | 3 | 2019 | 223583 | 0.010 |
Why?
|
Child | 2 | 2011 | 80906 | 0.010 |
Why?
|
Prostaglandin Endoperoxides, Synthetic | 1 | 1992 | 58 | 0.010 |
Why?
|
15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid | 1 | 1992 | 64 | 0.010 |
Why?
|
Cell Membrane | 2 | 1992 | 3657 | 0.010 |
Why?
|
Blood Proteins | 1 | 1997 | 1191 | 0.010 |
Why?
|
Energy Intake | 1 | 1999 | 2145 | 0.010 |
Why?
|
Trypsin | 1 | 1992 | 491 | 0.010 |
Why?
|
Adenosine Diphosphate | 1 | 1992 | 422 | 0.010 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 1992 | 1057 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2016 | 36742 | 0.000 |
Why?
|
Vasoconstrictor Agents | 1 | 1992 | 656 | 0.000 |
Why?
|
Adolescent | 2 | 2011 | 89155 | 0.000 |
Why?
|
Anemia | 1 | 1997 | 1514 | 0.000 |
Why?
|
Receptors, Transferrin | 1 | 1989 | 300 | 0.000 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 1997 | 3612 | 0.000 |
Why?
|
Quality of Life | 1 | 1987 | 13489 | 0.000 |
Why?
|
Length of Stay | 1 | 1999 | 6495 | 0.000 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 1992 | 3813 | 0.000 |
Why?
|
Blotting, Western | 1 | 1992 | 5024 | 0.000 |
Why?
|
Young Adult | 1 | 2011 | 60048 | 0.000 |
Why?
|
Risk Factors | 1 | 2011 | 74936 | 0.000 |
Why?
|
Spleen | 1 | 1989 | 2295 | 0.000 |
Why?
|
DNA Replication | 1 | 1989 | 1427 | 0.000 |
Why?
|
Liver | 1 | 1997 | 7574 | 0.000 |
Why?
|
Statistics as Topic | 1 | 1987 | 2357 | 0.000 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 1992 | 2764 | 0.000 |
Why?
|
Phenotype | 1 | 1997 | 16723 | 0.000 |
Why?
|
Treatment Outcome | 1 | 1999 | 65364 | 0.000 |
Why?
|
Retrospective Studies | 1 | 1999 | 81746 | 0.000 |
Why?
|
Follow-Up Studies | 1 | 1987 | 39345 | 0.000 |
Why?
|